Medindia LOGIN REGISTER
Medindia

Cyclizine Interaction with other Drugs


Cyclizine is a histamine H1 inhibitor prescribed for adults and children 6 years and above for the treatment of nausea and vomiting caused due to • Motion sickness • Surgeries • Drugs like narcotic analgesics and by general anaesthetics given in the post-operative period • Radiotherapy, especially for breast cancer • Menière's disease and other forms of vestibular disturbance (rarely) Cyclizine was discovered in 1947.

Cyclizine Interaction with 314 drugs. Find out more in the list below:

4-Hydroxybutyric Acid


The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Cyclizine.

Acepromazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Acepromazine.

Aceprometazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Aceprometazine.

Advertisement

Alfaxalone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Alfaxalone.

Alfentanil


The risk or severity of adverse effects can be increased when Alfentanil is combined with Cyclizine.

Alphaprodine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Alphaprodine.

Advertisement

Alprazolam


The risk or severity of adverse effects can be increased when Alprazolam is combined with Cyclizine.

Amisulpride


The risk or severity of adverse effects can be increased when Cyclizine is combined with Amisulpride.

Amitriptyline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyclizine.

Advertisement

Amobarbital


The risk or severity of adverse effects can be increased when Amobarbital is combined with Cyclizine.

Amoxapine


The risk or severity of adverse effects can be increased when Amoxapine is combined with Cyclizine.

Amphetamine


Amphetamine may decrease the sedative activities of Cyclizine.

Aripiprazole


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Cyclizine.

Articaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Articaine.

Asenapine


The risk or severity of adverse effects can be increased when Asenapine is combined with Cyclizine.

Azelastine


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Baclofen


The risk or severity of adverse effects can be increased when Baclofen is combined with Cyclizine.

Barbital


The risk or severity of adverse effects can be increased when Cyclizine is combined with Barbital.

Benoxinate


The risk or severity of adverse effects can be increased when Cyclizine is combined with Oxybuprocaine.

Benperidol


The risk or severity of adverse effects can be increased when Cyclizine is combined with Benperidol.

Benzocaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Benzocaine.

Benzphetamine


Benzphetamine may decrease the sedative activities of Cyclizine.

Benzyl Alcohol


The risk or severity of adverse effects can be increased when Cyclizine is combined with Benzyl alcohol.

Benzylpenicilloyl polylysine


Cyclizine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.

BETAHISTINE


The therapeutic efficacy of Betahistine can be decreased when used in combination with Cyclizine.

Brexpiprazole


The risk or severity of adverse effects can be increased when Cyclizine is combined with Brexpiprazole.

Brimonidine


Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Bromazepam


The risk or severity of adverse effects can be increased when Bromazepam is combined with Cyclizine.

Bromperidol


The risk or severity of adverse effects can be increased when Cyclizine is combined with Bromperidol.

Brompheniramine


The risk or severity of adverse effects can be increased when Brompheniramine is combined with Cyclizine.

Brotizolam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Brotizolam.

Bupivacaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Bupivacaine.

Buprenorphine


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.

Buspirone


The risk or severity of adverse effects can be increased when Buspirone is combined with Cyclizine.

Butabarbital


The risk or severity of adverse effects can be increased when Butabarbital is combined with Cyclizine.

Butalbital


The risk or severity of adverse effects can be increased when Butalbital is combined with Cyclizine.

Butamben


The risk or severity of adverse effects can be increased when Cyclizine is combined with Butamben.

Butobarbital


The risk or severity of adverse effects can be increased when Cyclizine is combined with Butethal.

Butorphanol


The risk or severity of adverse effects can be increased when Butorphanol is combined with Cyclizine.

Carbamazepine


The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cyclizine.

Carbinoxamine


The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Cyclizine.

Carisoprodol


The risk or severity of adverse effects can be increased when Carisoprodol is combined with Cyclizine.

Cetirizine


The risk or severity of adverse effects can be increased when Cetirizine is combined with Cyclizine.

Chloral Hydrate


The risk or severity of adverse effects can be increased when Cyclizine is combined with Chloral hydrate.

Chlordiazepoxide


The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Cyclizine.

Chlormethiazole


The risk or severity of adverse effects can be increased when Cyclizine is combined with clomethiazole.

Chlormezanone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Chlormezanone.

Chloroprocaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Chloroprocaine.

Chlorpheniramine


The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Cyclizine.

CHLORPHENIRAMINE POLISTIREX


The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Cyclizine.

Chlorpromazine


The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Cyclizine.

Chlorprothixene


The risk or severity of adverse effects can be increased when Cyclizine is combined with Chlorprothixene.

Chlorzoxazone


The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Cyclizine.

Citalopram


The risk or severity of adverse effects can be increased when Cyclizine is combined with Citalopram.

Clemastine


The risk or severity of adverse effects can be increased when Clemastine is combined with Cyclizine.

Clidinium


The risk or severity of adverse effects can be increased when Clidinium is combined with Cyclizine.

Clidinium bromide


The risk or severity of adverse effects can be increased when Clidinium is combined with Cyclizine.

Clobazam


The risk or severity of adverse effects can be increased when Clobazam is combined with Cyclizine.

Clomipramine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Clomipramine.

Clonazepam


The risk or severity of adverse effects can be increased when Clonazepam is combined with Cyclizine.

Clonidine


The risk or severity of adverse effects can be increased when Clonidine is combined with Cyclizine.

Clorazepate


The risk or severity of adverse effects can be increased when Clorazepate is combined with Cyclizine.

CLORAZEPIC ACID


The risk or severity of adverse effects can be increased when Clorazepate is combined with Cyclizine.

Clozapine


The risk or severity of adverse effects can be increased when Clozapine is combined with Cyclizine.

Cocaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Cocaine.

Codeine


The risk or severity of adverse effects can be increased when Codeine is combined with Cyclizine.

Codeine Anhydrous


The risk or severity of adverse effects can be increased when Codeine is combined with Cyclizine.

CODEINE POLISTIREX


The risk or severity of adverse effects can be increased when Codeine is combined with Cyclizine.

Cyclobenzaprine


The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Cyclizine.

Cyproheptadine


The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Cyclizine.

Dantrolene


The risk or severity of adverse effects can be increased when Cyclizine is combined with Dantrolene.

Dapiprazole


The risk or severity of adverse effects can be increased when Cyclizine is combined with Dapiprazole.

Desflurane


The risk or severity of adverse effects can be increased when Desflurane is combined with Cyclizine.

Desipramine


The risk or severity of adverse effects can be increased when Desipramine is combined with Cyclizine.

Desloratadine


The risk or severity of adverse effects can be increased when Desloratadine is combined with Cyclizine.

Desvenlafaxine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Desvenlafaxine.

Dexbrompheniramine


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Cyclizine.

Dexmedetomidine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Dexmedetomidine.

Dextroamphetamine


Dextroamphetamine may decrease the sedative activities of Cyclizine.

Dextromoramide


The risk or severity of adverse effects can be increased when Cyclizine is combined with Dextromoramide.

Dezocine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Dezocine.

Diazepam


The risk or severity of adverse effects can be increased when Diazepam is combined with Cyclizine.

Dibucaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Cinchocaine.

Diethylpropion


Diethylpropion may decrease the sedative activities of Cyclizine.

Difenoxin


The risk or severity of adverse effects can be increased when Cyclizine is combined with Difenoxin.

Dihydrocodeine


The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Cyclizine.

Dimenhydrinate


The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Cyclizine.

Diphenhydramine


The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Cyclizine.

Diphenoxylate


The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Cyclizine.

Doxepin


The risk or severity of adverse effects can be increased when Doxepin is combined with Cyclizine.

Doxylamine


Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Droperidol


Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Duloxetine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Duloxetine.

Dyclonine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Dyclonine.

Efavirenz


The risk or severity of adverse effects can be increased when Efavirenz is combined with Cyclizine.

Enflurane


The risk or severity of adverse effects can be increased when Cyclizine is combined with Enflurane.

Entacapone


The risk or severity of adverse effects can be increased when Entacapone is combined with Cyclizine.

Escitalopram


The risk or severity of adverse effects can be increased when Cyclizine is combined with Escitalopram.

Estazolam


The risk or severity of adverse effects can be increased when Estazolam is combined with Cyclizine.

Eszopiclone


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cyclizine.

Ethanol


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Ethchlorvynol


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ethchlorvynol.

Ethosuximide


The risk or severity of adverse effects can be increased when Ethosuximide is combined with Cyclizine.

Ethotoin


The risk or severity of adverse effects can be increased when Ethotoin is combined with Cyclizine.

Ethyl Chloride


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ethyl chloride.

Ethyl Loflazepate


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ethyl loflazepate.

Ethylmorphine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ethylmorphine.

Etidocaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Etidocaine.

Etifoxine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Etifoxine.

Etomidate


The risk or severity of adverse effects can be increased when Cyclizine is combined with Etomidate.

Ezogabine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ezogabine.

Felbamate


The risk or severity of adverse effects can be increased when Felbamate is combined with Cyclizine.

Fentanyl


The risk or severity of adverse effects can be increased when Fentanyl is combined with Cyclizine.

Fexofenadine


The risk or severity of adverse effects can be increased when Fexofenadine is combined with Cyclizine.

Flibanserin


The risk or severity of adverse effects can be increased when Cyclizine is combined with Flibanserin.

Flunarizine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Flunarizine.

Flunitrazepam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Flunitrazepam.

Fluoxetine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Fluoxetine.

Flupenthixol


The risk or severity of adverse effects can be increased when Flupentixol is combined with Cyclizine.

Fluphenazine


The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cyclizine.

Flurazepam


The risk or severity of adverse effects can be increased when Flurazepam is combined with Cyclizine.

Fluspirilene


The risk or severity of adverse effects can be increased when Cyclizine is combined with Fluspirilene.

Fluticasone propionate


The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cyclizine.

Fluvoxamine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Fluvoxamine.

Fosphenytoin


The risk or severity of adverse effects can be increased when Cyclizine is combined with Fosphenytoin.

Fospropofol


The risk or severity of adverse effects can be increased when Cyclizine is combined with Fospropofol.

Gabapentin


The risk or severity of adverse effects can be increased when Gabapentin is combined with Cyclizine.

Gabapentin Enacarbil


The risk or severity of adverse effects can be increased when Cyclizine is combined with Gabapentin Enacarbil.

Glutethimide


The risk or severity of adverse effects can be increased when Cyclizine is combined with Glutethimide.

Guanfacine


The risk or severity of adverse effects can be increased when Guanfacine is combined with Cyclizine.

Halazepam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Halazepam.

Haloperidol


The risk or severity of adverse effects can be increased when Haloperidol is combined with Cyclizine.

Halothane


The risk or severity of adverse effects can be increased when Cyclizine is combined with Halothane.

Heroin


The risk or severity of adverse effects can be increased when Cyclizine is combined with Heroin.

Hexobarbital


The risk or severity of adverse effects can be increased when Cyclizine is combined with Hexobarbital.

Hyaluronidase


The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cyclizine.

Hyaluronidase, Ovine


The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cyclizine.

Hydrocodone


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.

HYDROCODONE POLISTIREX


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.

Hydromorphone


The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cyclizine.

Hydroxyzine


Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Iloperidone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Iloperidone.

Imipramine


The risk or severity of adverse effects can be increased when Imipramine is combined with Cyclizine.

Isoflurane


The risk or severity of adverse effects can be increased when Isoflurane is combined with Cyclizine.

Ketamine


The risk or severity of adverse effects can be increased when Ketamine is combined with Cyclizine.

Ketazolam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ketazolam.

Lamotrigine


The risk or severity of adverse effects can be increased when Lamotrigine is combined with Cyclizine.

Levetiracetam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Levetiracetam.

Levobupivacaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Levobupivacaine.

Levocabastine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Levocabastine.

Levocetirizine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Levocetirizine.

Levodopa


The risk or severity of adverse effects can be increased when Cyclizine is combined with Levodopa.

Levomethadyl


The risk or severity of adverse effects can be increased when Cyclizine is combined with Levomethadyl Acetate.

Levomilnacipran


The risk or severity of adverse effects can be increased when Cyclizine is combined with Levomilnacipran.

Levorphanol


The risk or severity of adverse effects can be increased when Levorphanol is combined with Cyclizine.

Lidocaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Lidocaine.

Lisdexamfetamine


Lisdexamfetamine may decrease the sedative activities of Cyclizine.

Lisdexamfetamine Dimesylate


Lisdexamfetamine may decrease the sedative activities of Cyclizine.

Lithium


The risk or severity of adverse effects can be increased when Cyclizine is combined with Lithium.

Lithium Cation


The risk or severity of adverse effects can be increased when Cyclizine is combined with Lithium.

Lofexidine


The therapeutic efficacy of Cyclizine can be increased when used in combination with Lofexidine.

Loratadine


The risk or severity of adverse effects can be increased when Loratadine is combined with Cyclizine.

Lorazepam


The risk or severity of adverse effects can be increased when Lorazepam is combined with Cyclizine.

Lormetazepam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Lormetazepam.

Loxapine


The risk or severity of adverse effects can be increased when Loxapine is combined with Cyclizine.

Lurasidone


The risk or severity of adverse effects can be increased when Lurasidone is combined with Cyclizine.

Magnesium Sulfate


The therapeutic efficacy of Cyclizine can be increased when used in combination with Magnesium sulfate.

MAGNESIUM SULFATE ANHYDROUS


The therapeutic efficacy of Cyclizine can be increased when used in combination with Magnesium sulfate.

Maprotiline


The risk or severity of adverse effects can be increased when Maprotiline is combined with Cyclizine.

Meclizine


The risk or severity of adverse effects can be increased when Meclizine is combined with Cyclizine.

Melatonin


The risk or severity of adverse effects can be increased when Cyclizine is combined with Melatonin.

Meperidine


The risk or severity of adverse effects can be increased when Pethidine is combined with Cyclizine.

Mephentermine


Mephentermine may decrease the sedative activities of Cyclizine.

Mephobarbital


The risk or severity of adverse effects can be increased when Cyclizine is combined with Methylphenobarbital.

Mepivacaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Mepivacaine.

Meprobamate


The risk or severity of adverse effects can be increased when Meprobamate is combined with Cyclizine.

Mesoridazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Mesoridazine.

Metaxalone


The risk or severity of adverse effects can be increased when Metaxalone is combined with Cyclizine.

Methadone


The risk or severity of adverse effects can be increased when Methadone is combined with Cyclizine.

Methadyl Acetate


The risk or severity of adverse effects can be increased when Cyclizine is combined with Methadyl Acetate.

Methamphetamine


Methamphetamine may decrease the sedative activities of Cyclizine.

Methapyrilene


The risk or severity of adverse effects can be increased when Cyclizine is combined with Methapyrilene.

Methaqualone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Methaqualone.

Methocarbamol


The risk or severity of adverse effects can be increased when Methocarbamol is combined with Cyclizine.

Methohexital


The risk or severity of adverse effects can be increased when Methohexital is combined with Cyclizine.

Methotrimeprazine


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.

Methoxyflurane


The risk or severity of adverse effects can be increased when Cyclizine is combined with Methoxyflurane.

Methsuximide


The risk or severity of adverse effects can be increased when Cyclizine is combined with Methsuximide.

Metylperon


The risk or severity of adverse effects can be increased when Cyclizine is combined with Melperone.

Metyrosine


Cyclizine may increase the sedative activities of Metyrosine.

Midazolam


The risk or severity of adverse effects can be increased when Midazolam is combined with Cyclizine.

Milnacipran


The risk or severity of adverse effects can be increased when Cyclizine is combined with Milnacipran.

Minocycline


Minocycline may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Mirtazapine


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.

Molindone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Molindone.

Morphine


The risk or severity of adverse effects can be increased when Morphine is combined with Cyclizine.

Nabilone


Nabilone may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Nalbuphine


The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cyclizine.

Nefazodone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Nefazodone.

Nitrazepam


The risk or severity of adverse effects can be increased when Nitrazepam is combined with Cyclizine.

Nitrous Oxide


The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Cyclizine.

Nordazepam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Nordazepam.

Norflurane


The risk or severity of adverse effects can be increased when Cyclizine is combined with Norflurane.

Normethadone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Normethadone.

Nortriptyline


The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cyclizine.

Olanzapine


The risk or severity of adverse effects can be increased when Olanzapine is combined with Cyclizine.

Olopatadine


The risk or severity of adverse effects can be increased when Olopatadine is combined with Cyclizine.

Ondansetron


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ondansetron.

Opium


The risk or severity of adverse effects can be increased when Cyclizine is combined with Opium.

Orphenadrine


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.

Oxazepam


The risk or severity of adverse effects can be increased when Oxazepam is combined with Cyclizine.

Oxprenolol


The risk or severity of adverse effects can be increased when Cyclizine is combined with Oxprenolol.

Oxycodone


The risk or severity of adverse effects can be increased when Oxycodone is combined with Cyclizine.

Oxymorphone


The risk or severity of adverse effects can be increased when Oxymorphone is combined with Cyclizine.

p-Hydroxyamphetamine


Hydroxyamphetamine may decrease the sedative activities of Cyclizine.

Paliperidone


The risk or severity of adverse effects can be increased when Paliperidone is combined with Cyclizine.

Paraldehyde


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.

Paregoric


The risk or severity of adverse effects can be increased when Morphine is combined with Cyclizine.

Paroxetine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Paroxetine.

Pentazocine


The risk or severity of adverse effects can be increased when Pentazocine is combined with Cyclizine.

Pentobarbital


The risk or severity of adverse effects can be increased when Pentobarbital is combined with Cyclizine.

Perampanel


Perampanel may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Perazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Perazine.

Perphenazine


The risk or severity of adverse effects can be increased when Perphenazine is combined with Cyclizine.

Phenobarbital


The risk or severity of adverse effects can be increased when Phenobarbital is combined with Cyclizine.

Phenoxyethanol


The risk or severity of adverse effects can be increased when Cyclizine is combined with Phenoxyethanol.

Phentermine


Phentermine may decrease the sedative activities of Cyclizine.

PHENTERMINE RESIN


Phentermine may decrease the sedative activities of Cyclizine.

Phenytoin


The risk or severity of adverse effects can be increased when Phenytoin is combined with Cyclizine.

Pimozide


The risk or severity of adverse effects can be increased when Pimozide is combined with Cyclizine.

Pipamperone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Pipamperone.

Pipothiazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Pipotiazine.

Pirinitramide


The risk or severity of adverse effects can be increased when Cyclizine is combined with Piritramide.

Pizotyline


The risk or severity of adverse effects can be increased when Cyclizine is combined with Pizotifen.

Pomalidomide


The risk or severity of adverse effects can be increased when Cyclizine is combined with Pomalidomide.

Pramipexole


Cyclizine may increase the sedative activities of Pramipexole.

Pramoxine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Pramocaine.

Prazepam


The risk or severity of adverse effects can be increased when Cyclizine is combined with Prazepam.

Pregabalin


The therapeutic efficacy of Cyclizine can be increased when used in combination with Pregabalin.

Prilocaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Prilocaine.

Primidone


The risk or severity of adverse effects can be increased when Primidone is combined with Cyclizine.

Procaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Procaine.

Prochlorperazine


The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Cyclizine.

Promazine


The risk or severity of adverse effects can be increased when Promazine is combined with Cyclizine.

Promethazine


The risk or severity of adverse effects can be increased when Promethazine is combined with Cyclizine.

Proparacaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Proparacaine.

Propofol


The risk or severity of adverse effects can be increased when Propofol is combined with Cyclizine.

Propoxyphene


The risk or severity of adverse effects can be increased when Cyclizine is combined with Dextropropoxyphene.

Protriptyline


The risk or severity of adverse effects can be increased when Protriptyline is combined with Cyclizine.

Pseudoephedrine


Pseudoephedrine may decrease the sedative activities of Cyclizine.

Quazepam


The risk or severity of adverse effects can be increased when Quazepam is combined with Cyclizine.

Quetiapine


The risk or severity of adverse effects can be increased when Quetiapine is combined with Cyclizine.

Quetiapine fumarate


The risk or severity of adverse effects can be increased when Quetiapine is combined with Cyclizine.

Ramelteon


The risk or severity of adverse effects can be increased when Ramelteon is combined with Cyclizine.

Remifentanil


The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyclizine.

Remoxipride


The risk or severity of adverse effects can be increased when Cyclizine is combined with Remoxipride.

Reserpine


The risk or severity of adverse effects can be increased when Reserpine is combined with Cyclizine.

Risperidone


The risk or severity of adverse effects can be increased when Risperidone is combined with Cyclizine.

Ropinirole


Cyclizine may increase the sedative activities of Ropinirole.

Ropivacaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ropivacaine.

Rotigotine


Cyclizine may increase the sedative activities of Rotigotine.

Rufinamide


The risk or severity of adverse effects can be increased when Rufinamide is combined with Cyclizine.

Scopolamine


The risk or severity of adverse effects can be increased when Scopolamine is combined with Cyclizine.

Scopolamine Hydrobromide


The risk or severity of adverse effects can be increased when Scopolamine is combined with Cyclizine.

Secobarbital


The risk or severity of adverse effects can be increased when Secobarbital is combined with Cyclizine.

Sertindole


The risk or severity of adverse effects can be increased when Cyclizine is combined with Sertindole.

Sertraline


The risk or severity of adverse effects can be increased when Cyclizine is combined with Sertraline.

Sevoflurane


The risk or severity of adverse effects can be increased when Sevoflurane is combined with Cyclizine.

Sodium Oxybate


Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Sufentanil


The risk or severity of adverse effects can be increased when Sufentanil is combined with Cyclizine.

Sulpiride


The risk or severity of adverse effects can be increased when Cyclizine is combined with Sulpiride.

Suvorexant


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.

Tapentadol


Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Tasimelteon


The risk or severity of adverse effects can be increased when Cyclizine is combined with Tasimelteon.

Temazepam


The risk or severity of adverse effects can be increased when Temazepam is combined with Cyclizine.

Tetrabenazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Tetrabenazine.

Tetracaine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Tetracaine.

Tetracaine hydrochloride


The risk or severity of adverse effects can be increased when Cyclizine is combined with Tetracaine.

Tetrahydrocannabinol


Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.

Thalidomide


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.

Thiamylal


The risk or severity of adverse effects can be increased when Cyclizine is combined with Thiamylal.

Thiopental


The risk or severity of adverse effects can be increased when Cyclizine is combined with Thiopental.

Thiopental Sodium


The risk or severity of adverse effects can be increased when Cyclizine is combined with Thiopental.

Thioridazine


The risk or severity of adverse effects can be increased when Thioridazine is combined with Cyclizine.

Thiothixene


The risk or severity of adverse effects can be increased when Thiothixene is combined with Cyclizine.

Tiagabine


The risk or severity of adverse effects can be increased when Tiagabine is combined with Cyclizine.

Tiapride


The risk or severity of adverse effects can be increased when Cyclizine is combined with Tiapride.

Tizanidine


The risk or severity of adverse effects can be increased when Tizanidine is combined with Cyclizine.

Tolcapone


The risk or severity of adverse effects can be increased when Tolcapone is combined with Cyclizine.

Topiramate


The risk or severity of adverse effects can be increased when Topiramate is combined with Cyclizine.

Tramadol


The risk or severity of adverse effects can be increased when Tramadol is combined with Cyclizine.

Tranylcypromine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Tranylcypromine.

Trazodone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Trazodone.

Triazolam


The risk or severity of adverse effects can be increased when Triazolam is combined with Cyclizine.

Triazulenone


The risk or severity of adverse effects can be increased when Cyclizine is combined with Loprazolam.

Trifluoperazine


The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cyclizine.

Triflupromazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Triflupromazine.

Trimipramine


The risk or severity of adverse effects can be increased when Trimipramine is combined with Cyclizine.

Triprolidine


The risk or severity of adverse effects can be increased when Triprolidine is combined with Cyclizine.

Urethane


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ethyl carbamate.

Valproate


The risk or severity of adverse effects can be increased when Cyclizine is combined with Valproic Acid.

Valproic Acid


The risk or severity of adverse effects can be increased when Cyclizine is combined with Valproic Acid.

Venlafaxine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Venlafaxine.

Vigabatrin


The risk or severity of adverse effects can be increased when Vigabatrin is combined with Cyclizine.

Vortioxetine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Vortioxetine.

Xylazine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Xylazine.

Zaleplon


The risk or severity of adverse effects can be increased when Zaleplon is combined with Cyclizine.

Ziconotide


The risk or severity of adverse effects can be increased when Cyclizine is combined with Ziconotide.

Ziprasidone


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Cyclizine.

Zolpidem


Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.

Zonisamide


The risk or severity of adverse effects can be increased when Zonisamide is combined with Cyclizine.

Zopiclone


The risk or severity of adverse effects can be increased when Zopiclone is combined with Cyclizine.

Zotepine


The risk or severity of adverse effects can be increased when Cyclizine is combined with Zotepine.

Zuclopenthixol


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Cyclizine.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Complete Hypertension Guide: Control, Causes and Prevention.
Stay Connected
Available on the Android Market Available on the App Store